Article
Altered Plasmodium falciparum Sensitivity to the Antiretroviral Protease Inhibitor Lopinavir Associated with Polymorphisms in pfmdr1.
Antimicrobial agents and chemotherapy - 1 Jan 2017
Sonoiki Ebere, Nsanzabana Christian, Legac Jennifer, Sindhe Kirthana M V, DeRisi Joseph, Rosenthal Philip J
Abstract excerpt
The HIV protease inhibitor lopinavir inhibits Plasmodium falciparum aspartic proteases (plasmepsins) and parasite development, and children receiving lopinavir-ritonavir experienced fewer episodes of malaria than those receiving other antiretroviral regimens. Resistance to lopinavir was selected in vitro over ∼9 months, with ∼4-fold decreased sensitivity. Whole-genome sequencing of resistant parasites showed a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
